Search Results - "McGrail, Kieran"
-
1
Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform
Published in Proceedings of the National Academy of Sciences - PNAS (19-09-2017)“…Identified as a major biomarker for type 1 diabetes (T1D) diagnosis, zinc transporter 8 autoantibody (ZnT8A) has shown promise for staging disease risk and…”
Get full text
Journal Article -
2
Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis
Published in Diabetes (New York, N.Y.) (01-04-2021)“…We and others previously demonstrated that a type 1 diabetes genetic risk score (GRS) improves the ability to predict disease progression and onset in at-risk…”
Get full text
Journal Article -
3
Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes
Published in Diabetologia (01-08-2021)“…Aims/hypothesis The circadian clock influences both diabetes and immunity. Our goal in this study was to characterise more thoroughly the circadian patterns of…”
Get full text
Journal Article -
4
A genomic data archive from the Network for Pancreatic Organ donors with Diabetes
Published in Scientific data (26-05-2023)“…The Network for Pancreatic Organ donors with Diabetes (nPOD) is the largest biorepository of human pancreata and associated immune organs from donors with type…”
Get full text
Journal Article -
5
1729-P: Circadian Patterns of Autoimmune Components in the Blood of Persons with Type 1 Diabetes: Implications for the Timing of Blood Sampling
Published in Diabetes (New York, N.Y.) (01-06-2019)“…Purpose: Immune populations and cytokines are known to exhibit distinct circadian ("daily") variations. We sought to characterize circadian-related immune…”
Get full text
Journal Article -
6
No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (01-03-2007)“…No Alterations in the Frequency of FOXP3 + Regulatory T-Cells in Type 1 Diabetes Todd Brusko 1 , Clive Wasserfall 1 , Kieran McGrail 1 , Richard Schatz 1 ,…”
Get full text
Journal Article -
7
Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes
Published in Diabetes care (01-11-2009)“…OBJECTIVE: Interest continues to grow regarding the therapeutic potential for umbilical cord blood therapies to modulate autoimmune disease. We conducted an…”
Get full text
Journal Article -
8
Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide
Published in Diabetes care (01-12-2011)“…OBJECTIVE: We conducted an open-label, phase I study using autologous umbilical cord blood (UCB) infusion to ameliorate type 1 diabetes (T1D). Having…”
Get full text
Journal Article -
9
339 A serum exocrine enzyme as a biomarker of response to immunotherapy in type 1 diabetes
Published in Journal of clinical and translational science (01-04-2022)“…OBJECTIVES/GOALS: We assessed the relationship between C-peptide preservation and a serum exocrine pancreatic enzyme (trypsin) in a recently concluded clinical…”
Get full text
Journal Article -
10
Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area
Published in Journal of diabetes and its complications (01-05-2010)“…Abstract Objective The notion of combining immunomodulatory agents with the incretin exendin-4 (Ex-4) has seen considerable favor as a potential therapy for…”
Get full text
Journal Article -
11
1623-P: Artificial Intelligence with QuPATH in Pancreatic Cell Classification
Published in Diabetes (New York, N.Y.) (01-06-2024)“…We developed Artificial Intelligence classification algorithms in QuPATH containing both supervised and unsupervised components to quantify and classify the…”
Get full text
Journal Article -
12
Regulatory T Cells Require Serum for Suppression of Effector T Cell Proliferation and Express Stable Membrane-bound CD25
Published in Clinical immunology (Orlando, Fla.) (01-01-2007)Get full text
Journal Article -
13
Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size
Published in Diabetes (New York, N.Y.) (01-04-2021)“…Exocrine pancreas abnormalities are increasingly recognized as features of type 1 diabetes. We previously reported reduced serum trypsinogen levels and in a…”
Get full text
Journal Article -
14
Serum Trypsinogen Levels in Type 1 Diabetes
Published in Diabetes care (01-04-2017)“…The pancreas in type 1 diabetes exhibits decreased size (weight/volume) and abnormal exocrine morphology. Serum trypsinogen levels are an established marker of…”
Get full text
Journal Article -
15
Exocrine Pancreatic Function as a Novel Biomarker in Pre-T1D
Published in Diabetes (New York, N.Y.) (01-07-2018)“…Recent studies demonstrated reduced serum trypsinogen levels as well as pancreatic weight/volume in patients with type 1 diabetes (T1D) and…”
Get full text
Journal Article -
16
Exendin-4 Therapy in NOD Mice with New-Onset Diabetes Increases Regulatory T Cell Frequency
Published in Annals of the New York Academy of Sciences (01-12-2008)“…Recent studies, albeit controversial, have suggested that the incretin exendin‐4 (Ex‐4) is capable of inducing β cell proliferation in vivo. Furthermore, this…”
Get full text
Journal Article -
17
No Alterations in the Frequency of FOXP3^sup +^ Regulatory T-Cells in Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (01-03-2007)“…Regulatory T-cells (Tregs) play a critical role in maintaining dominant peripheral tolerance. Previous characterizations of Tregs in type 1 diabetes have used…”
Get full text
Journal Article -
18
No Alterations in the Frequency of FOXP3 super(+) Regulatory T-Cells in Type 1 Diabetes
Published in Diabetes (New York, N.Y.) (01-03-2007)“…Regulatory T-cells (Tregs) play a critical role in maintaining dominant peripheral tolerance. Previous characterizations of Tregs in type 1 diabetes have used…”
Get full text
Journal Article -
19
No alterations in the frequency of FOXP[3.sup.+] regulatory T-cells in type 1 diabetes
Published in Diabetes (New York, N.Y.) (01-03-2007)“…Regulatory T-cells (Tregs) play a critical role in maintaining dominant peripheral tolerance. Previous characterizations of Tregs in type 1 diabetes have used…”
Get full text
Journal Article